Inhalation delivery of manganese superoxide dismutase-plasmid/liposomes protects the murine lung from irradiation damage
- 3 March 2005
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 12 (8) , 685-693
- https://doi.org/10.1038/sj.gt.3302468
Abstract
Intratracheal injection of manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) complexes has been demonstrated to delay the onset and reduce the extent of ionizing irradiation-induced murine pulmonary organizing alveolitis/fibrosis. To facilitate translation of this modality to clinical fractionated radiotherapy, inhalation delivery of MnSOD-PL was developed using an ultrasonic nebulizer. Transgene product was quantitated by immunohistochemical quantitation and pulmonary tissue levels of MnSOD biochemical activity. C57BL/6NHsd female mice demonstrated a plasmid dose-dependent increased expression of MnSOD transgene product over the range of 250 g–2.5 mg of MnSOD-PL administered over a constant 5 min interval. Delivery of a constant concentration of 500 g of MnSOD-PL with varying times of administration ranging from 0.5 to 10 min demonstrated optimal MnSOD expression at 5 min. Mice pretreated by inhalation delivery of MnSOD-PL demonstrated significantly improved survival after 20 Gy single fraction irradiation to both lungs compared to LacZ-PL inhalation-treated or irradiated control mice. Mice receiving 10 fractions of 3.5 cGy demonstrated increased pulmonary MnSOD transgene product activity by a protocol of every Monday–Wednesday or daily inhalation of MnSOD-PL. Thus, inhalation radioprotective gene therapy using MnSOD-PL provides a practical and effective method for delivery of lung-specific radioprotection during fractionated radiotherapy protocols in a mouse model.Keywords
This publication has 41 references indexed in Scilit:
- Ascorbate as a “redox sensor” and protector against irradiation-induced oxidative stress in 32D CL 3 hematopoietic cells and subclones overexpressing human manganese superoxide dismutaseInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Targeting expression of a transgene to the airway surface epithelium using a ciliated cell-specific promoterPublished by Elsevier ,2003
- Late radiation-related fibrosis: pathogenesis, manifestations, and current managementSeminars in Radiation Oncology, 2003
- Randomized Double-Blind Trial of Combined Modality Treatment With or Without Amifostine in Unresectable Stage III Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2003
- Adenovirus-Mediated Transfer and Overexpression of Heme Oxygenase 1 cDNA in Lung Prevents Bleomycin-Induced Pulmonary Fibrosis via a Fas–Fas Ligand-Independent PathwayHuman Gene Therapy, 2002
- Gene Transfer to the Pleural Mesothelium as a Strategy to Deliver Proteins to the Lung ParenchymaHuman Gene Therapy, 2002
- An algorithm for finding protein–DNA binding sites with applications to chromatin- immunoprecipitation microarray experimentsNature Biotechnology, 2002
- Gene Therapy for Acute DiseasesMolecular Therapy, 2001
- Targeting Transgene Expression for Cystic Fibrosis Gene TherapyMolecular Therapy, 2001
- Manganese [correction of Magnesium] superoxide dismutase (MnSOD) plasmid/liposome pulmonary radioprotective gene therapy: Modulation of irradiation-induced mRNA for IL-I, TNF-alpha, and TGF-beta correlates with delay of organizing alveolitis/fibrosisTransplantation and Cellular Therapy, 1999